PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer

Background: The polypyrimidine tract-binding protein (PTBP) nuclear ribonucleoprotein family of proteins, including PTBP1, PTBP2 and PTBP3, regulate the process of cell proliferation, differentiation, apoptosis and carcinogenesis. PTBPs exhibit oncogenic effects in certain tumors. However, the role...

Full description

Bibliographic Details
Main Authors: Chen Chen, Anquan Shang, Yuting Gao, Jingjuan Huang, Gege Liu, William C. Cho, Dong Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Molecular Biosciences
Subjects:
biomarkers
immunotherapy
pan-cancer
polypyrimidine tract-binding proteins
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.968458/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2022.968458/full

Similar Items